Tracers / [225Ac]Ac-crown-TATE
[225Ac]Ac-crown-TATE
Also written as [Ac-225]Ac-crown-TATE
- Radionuclide
- Ac-225 t½ 14284.8 min
- Modality
- Therapy
- Production route
- —
- Stage
- —
- Syntheses indexed
- 0
What it is
- Compound class
- somatostatin analogue peptide (crown-TATE, DOTA-TATE-type SSTR2-targeting peptide conjugate)
- Target / mechanism
- Somatostatin receptor 2 (SSTR2) PMID 37049918
- Clinical application
- Neuroendocrine tumours PMID 37049918
- Theranostic pair
- —
Regulatory status
- FDA
- —
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Clinical use
- Typical injected activity
- —
- Uptake time
- —
Reported in the literature. Not a dosing recommendation.
Published syntheses
No synthesis has been parsed for this agent yet.
Need this precursor?We can point you to suppliers for [225Ac]Ac-crown-TATE, or handle the enquiry for you.
Get in touchNotes
Added at stage 21 from therapy-discovered.xlsx (bulk PubMed search by isotope/therapy-type/known-agent, not individually researched yet) -- 2 articles found. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Compound class inferred from precursor name (not stated outright) -- PMID 37049918: 'crown-TATE was prepared using standardised Fmoc-based solid phase peptide synthesis (SPPS)'. Stage 26: this agent has NO own synthesis/characterisation data in the current corpus -- its only linked run(s) were unlinked (empty-quote recheck: appeared only as a control/comparator or in the wrong article).